TAK-603 selectively suppresses Th1-type cytokine production and inhibits the progression of adjuvant arthritis

Immunology

Volumn 92, Issue 1, 1997, Pages 75-83

  Ohta, Y ^a   Yamane, M ^a   Sohda, T ^a   Makino, H ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3,4 DIMETHOXYPHENYL) 6,7 DIMETHOXY 2 (1,2,4 TRIAZOL 1 YLMETHYL) 3 QUINOLINECARBOXYLIC ACID ETHYL ESTER; 4 (3,4 DIMETHOXYPHENYL) 6,7 DIMETHOXY 2 (1,2,4 TRIAZOLYLMETHYL) QUINOLINE 3 CARBOXYLIC ACID ETHYL ESTER; ANTIRHEUMATIC AGENT; COLLAGEN TYPE 2; CONCANAVALIN A; CYTOKINE; DIMETHYL SULFOXIDE; FREUND ADJUVANT; GAMMA INTERFERON; HOUSE DUST ALLERGEN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; METHYLCELLULOSE; OVALBUMIN; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HELPER CELL; INTRADERMAL DRUG ADMINISTRATION; LYMPHOCYTE CLONE; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PAW EDEMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030817020     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.d01-2288.x     Document Type: Article

References (47)

1. PAUL W.E. & SEDER R.A. (1994) Lymphocyte responses and cytokines. Cell 76, 241.
2. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16, 34.
3. LIPSKY P.E., DAVIS L.S., CUSH D.J. & OPPENHEIMER-MARKS N. (1989) The role of cytokines in the pathogenesis of rheumatoid arthritis. Springer Semin Immunopathol 11, 123.
4. SIMON A.K., SEIPELI E. & SIEPER J. (1994) Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 91, 8562.
5. DOLHAIN R.J.E.M., TER HAAR N.T., HOEFAKKER S. et al. (1995) Enhanced expression of interferon-gamma and interferon-gamma receptor in synovium of patients with rheumatoid arthritis compared with synovium of patients with osteoarthritis. Arthritis Rheum 38, S355.
6. YAMAMURA M., MORITA Y., OKAMOTO H. et al. (1995) The expression of interleukin-12 as an inducer of T helper type 1-specific immune responses in rheumatoid synovitis. Arthritis Rheum 38, S354.
7. SCHULZE-KOOPS H., LIPSKY P.E., KAVANAUGH A.F. & DAVIS L.S. (1995) Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. J Immunol 155, 5029.
8. OHTA Y., MAKINO H., FUKUDA S. et al. (1995) TAK-603, a new anti-rheumatic drug, suppresses autoimmune reactions and prevents articular destruction. Arthritis Rheum 38, S373.
9. OHTA Y., FUKUDA S., BABA A. et al. (1996) Immunomodulating and articular protecting activities of a new anti-rheumatic drug, TAK-603. Immunopharmacology 34, 19.
10. BABA A., KAWAMURA N., MAKINO H., OHTA Y., TAKETOMI S. & SOHDA T. (1996) Studies on disease modifying anti-rheumatic drugs (DMARDs): synthesis of novel quinoline and derivatives and their anti-inflammatory effect. J Med Chem 39, 5176.
11. + T-cell clones reactive to the murine malaria parasite Plasmodium chabaudi. Immunology 77, 99.
12. KIMOTO M. & FATHMAN C.G. (1980) Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation. J Exp Med 152, 759.
13. + T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection. Eur J Immunol 24, 1558.
14. CHOMCZYNSKI P. & SACCHI N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156.
15. CHOMCZYNSKI P. (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and protein from cell and tissue samples. BioTechniques 15, 532.
16. SAIKI R.K., GELFAND D.H., STOFFEL, S. et al. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487.
17. + T cells in vitro. J Immunol 156, 2406.
18. NOBLE A., STAYNOV D.Z. & KEMENY D.M. (1993) Generation of rat Th2-like cells in vitro is interleukin-4-dependent and inhibited by interferon-γ. Immunology 79, 562.
19. DIJKEMA R., VAN DER MEIDE P.H., POUWELS P.H., CASPERS M., DUBBELD M. & SCHELLEKENS H. (1985) Cloning and expression of the chromosomal immune interferon gene of the rat. EMBO J 4, 761.
20. + T cells. Eur J Immunol 21, 1187.
21. TSO J.Y., SUN X., KAO T., REECE K.S. & WU R. (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13, 2485.
22. SANDER B., ANDERSSON J. & ANDERSSON U. (1991) Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Rev 119, 65.
23. ASSENMACHER M., SCHMITZ J. & RADBRUCH A. (1994) Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-γ and interleukin-4-expressing cells. Eur J Immunol 24, 1097.
24. + T cells specific for Plasmodium chabaudi. Immunology 81, 216.
25. HEINZEL F.P., SADICK M.D., HOLADAY B.J., COFFMAN R.L. & LOCKSLEY R.M. (1989). Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis; evidence for expansion of distinct helper T cell subsets. J Exp Med 169, 59.
26. HSIEH C-S, MACATOMIA S.E., O'GARRA A. & MURPHY K.M. (1995) T cell genetic background determine default T helper phenotype development in vitro. J Exp Med 181, 713.
27. PERNIS A., GUPTA S., GOLLB K.J. et al. (1995) Lack of interferon γ receptor B chain and the prevention of interferon γ signaling in Th1 cells. Science 269, 245.
28. BACH E.A., SZABO S.J., DIPHE A.S. et al. (1995) Ligand-induced autoregulation of IFN-γ receptor B chain expression in T helper cell subsets. Science 270, 1215.
29. + T helper type 2 and type 0 cells by T helper type 1 cells via Fas, Fas-ligand interaction. Eur J Immunol 25, 2679.
30. GAJEWSKI T.F., SCHELL S.R. & FITCH F.W. (1990) Evidence implicating utilization of different T cell receptor-associated signaling pathways by ThI and Th2 clones. J Immunol 144, 4110.
31. TAMURA T., YANAGIDA T. & NARIUCHI H. (1993) Difference in signal transduction pathway for IL-2 and IL-4 production in T helper 1 and T helper 2 cell clones in response to anti-CD3. J Immunol 151, 6051.
32. TAMURA T., NAKANO H., NAGASE H. et al. (1995) Early activation signal transduction pathways of Th1 and Th2 cell clones stimulated with anti-CD3. J Immunol 155, 4692.
33. NOVAK T.J. & ROTHENBERG E.V. (1990) cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc Natl Acad Sci USA 87, 9353.
34. BETZ M. & FOX B.S. (1991) Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146, 108.
35. ROTT O., CASH E. & FLEISHER B. (1993) Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur J Immunol 23, 1745.
36. PEARSON C.M. & WOOD F.D. (1959) Studies of polyarthritis and other lesions, induced in rats by injection of mycobacterial adjuvant I. General clinical and pathologic characteristics and some modifying factors. Arthritis Rheum 2, 440.
37. GLENN E.M. & GRAY J. (1965) Adjuvant-induced polyarthritis in rats. Biologic and histologic background. Am J Vet Res 26, 1180.
38. WAKSMAN B.H., PEARSON C.M. & SHARP J.T. (1960) Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen. J Immunol 85, 1180.
39. PEARSON C.M. & WOOD F.D. (1964) Passive transfer of adjuvant arthritis by lymph node or spleen cells. J Exp Med 120, 547.
40. STUART J.M. & DIXON F.J. (1983) Serum transfer of collagen-induced arthritis in mice. J Exp Med 158, 378.
41. SEKI N., SUDO Y., YOSHIDA T. et al. (1988) Type-II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 140, 14 477.
42. DE FRANCO M., GILLE-PERRAMANT M.-F., MEVEL J.-C. & COUDERC J. (1995) T helper subset involvement in two high antibody responder lines of mice (Biozzi mice): HI (susceptible) and HII (resistant) to collagen-induced arthritis. Eur J Immunol 25, 132.
43. HESS H., GATELY M.K., RUDE E., SCHMITT D., SZELIGA J. & GERMANN T. (1996) High dose of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant. Eur J Immunol 26, 187.
44. TRENTHAM D.E., DYNESIUS-TRENTHAM R.A., ORAV E.J. et al. (1993) Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261, 1727.
45. CHEN Y., INOVE J.-I., MARKS R., GONNELLA P., KUCHROO V.K. & WEINER H.L. (1995) Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376, 177.
46. RACKE M.K., BONOMO A., SCOTT D.E. et al. (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180, 1961.
47. MAURI C., WILLIAMS R.O., WALMSLEY M. & FELDMANN M. (1996) Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 26, 1511.